BackCancer Genetics Overview

Cancer Genetics Other Assets

Cancer Genetics's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

Cancer Genetics Other Assets History

Loading

Cancer Genetics vs. peers: Other Assets Comparison

Loading

Cancer Genetics Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cancer Genetics (CGIX) FAQ

As of the most recent data (December 2020), CGIX shows a other assets of $0. Scroll down for historical charts and peer comparison views.

Tracking CGIX's other assets over time shows whether Cancer Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Cancer Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Cancer Genetics's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.